Oncologix Tech

Oncologix Tech Current Liabilities

Delisted·Sep 9, 2026

Current Liabilities of Oncologix Tech (OCLG) as of Oct 28, 2026.

Current Liabilities

0.00USD

Last updated:

Current Liabilities of Oncologix Tech is 2022 0.00 USD. Current Liabilities of Oncologix Tech was 2021 6.67 M USD. It decreases by % lower compared to the previous year.

The Oncologix Tech Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2014
4.02 M USD
Jan 1, 2015
4.56 M USD
Jan 1, 2016
5.97 M USD
Jan 1, 2017
7.47 M USD
Jan 1, 2019
6.67 M USD
Jan 1, 2020
6.67 M USD
Jan 1, 2021
6.67 M USD
Jan 1, 2022
0.00 USD
The Oncologix Tech Current Liabilities history
YEARCurrent LiabilitiesYoY
0.00USD-100.00%
6.67 MUSD0.00%
6.67 MUSD0.00%
6.67 MUSD-10.70%
7.47 MUSD+25.02%
5.97 MUSD+30.97%
4.56 MUSD+13.30%
4.02 MUSD+103.32%
1.98 MUSD+189.11%
684,606.00USD-22.21%
880,018.00USD+171.56%
324,055.00USD-87.94%
2.69 MUSD-21.34%
3.42 MUSD-3.24%
3.53 MUSD+82.78%
1.93 MUSD+591.42%
279,316.00USD-57.25%
653,439.00USD-56.49%
1.50 MUSD+10.21%
1.36 MUSD+732.27%
163,736.00USD-60.97%
419,542.00USD+31.23%
319,709.00USD-33.94%
483,954.00USD-53.47%
1.04 MUSD+29.12%
805,430.00USD+22.03%
660,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncologix Tech Stock analysis

What does Oncologix Tech do? Oncologix Tech, Inc. generates revenue through the operation and manufacture of medical device products. The company collaborates with manufacturers and stakeholders in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers. It reviews licenses and sublicense agreements with potential licensors and conducts research and due diligence on potential partners, joint-ventures, and acquisitions in the biotech industry. Oncologix Tech, Inc. seeks additional acquisitions of diagnostic and biotechnology opportunities to expand its portfolio. The firm's primary customers include partners, customers, vendors, and manufacturers within the medical device and biotech sectors. It targets opportunities in diagnostic and biotechnology fields through strategic acquisitions and partnerships. Oncologix Tech, Inc. focuses on executing agreements and conducting due diligence to secure new ventures in the biotech industry. Oncologix Tech, Inc. operates as a medical holding company with a focus on medical device products. It engages in reviewing licenses and sublicense agreements and conducts research on potential acquisitions. The company aims to expand its operations by acquiring diagnostic and biotechnology opportunities in the market. Oncologix Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncologix Tech stock

On Eulerpool you can find the complete historical development of Current Liabilities Oncologix Tech since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Oncologix Tech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Oncologix Tech

All Key Metrics — Oncologix Tech